The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Open accessAbstract
Gut microbiota are linked to chronic inflammation and carcinogenesis. Chemotherapy failure is the major cause of recurrence and poor prognosis in colorectal cancer patients. Here, we investigated the contribution of gut microbiota to chemoresistance in patients with colorectal cancer. We found that Fusobacterium (F.) nucleatum was abundant in colorectal cancer tissues in patients with recurrence post chemotherapy, and was associated with patient clinicopathological characterisitcs. Furthermore, our bioinformatic and functional studies demonstrated that F. nucleatum promoted colorectal cancer resistance to chemotherapy. Mechanistically, F. nucleatum targeted TLR4 and MYD88 innate immune signaling and specific microRNAs to activate the autophagy pathway and alter colorectal cancer chemotherapeutic response. Thus, F. nucleatum orchestrates a molecular network of the Toll-like receptor, microRNAs, and autophagy to clinically, biologically, and mechanistically control colorectal cancer chemoresistance. Measuring and targeting F. nucleatum and its associated pathway will yield valuable insight into clinical management and may ameliorate colorectal cancer patient outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a higher abundance of F nucleatum (present in approximately 10%–15% of tumors) has been associated with advanced disease stage, higher risk of recurrence, and shorter patient survival times.23, 26, 28”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [28]
In the citing paper
“Bioinformatic and functional studies indicated that F nucleatum activates innate immune responses, via TLR4 and MYD88, resulting in loss of specific microRNAs. This resulted in activation of autophagy activation and promotion of chemoresistance in patients with CRC.28”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [28]
In the citing paper
“F nucleatum was promotes resistance of CRC cells to chemotherapy.28”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [28]
In the citing paper
“Patients with post-chemotherapy recurrence had a higher abundance of F nucleatum in tumor tissues.28, 193”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [28]
In the citing paper
“(iii) chemoresistance via direct microbial metabolism (cytidine deaminase degradation of gemcitabine) in pancreatic cancer or indirect amplification of cancer cell autophagy in colorectal cancer (14, 104)”
From The microbiome and human cancer (2021) · cites this paper as [104]
In the citing paper
“regulate chemoresistance via direct drug metabolism by microbes [415, 416]”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [416]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
The resurgence of platinum-based cancer chemotherapy
Kèlland, L. R. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2167 · Cited by 4,733
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
Cited by
Sorted by citations
Items 301–400 of 1,002
B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells
Lu, H., Shi, T., Wang, M., Li, X., Gu, Y., Zhang, X., Zhang, G., & Chen, W. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1748991 · Cited by 82
Fidelle, M., Yonekura, S., Picard, M., Cogdill, A. P., Hollebecque, A., Roberti, M. P., & Zitvogel, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.600886 · Cited by 87
Yan, C., Wang, C., Hou, T., Guan, P., Qiao, Y., Guo, L., Teng, Y., Hu, X., & Wu, H. Y. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c19651 · Cited by 82
Lin, Z., Wan, A. H., Sun, L., Liang, H., Niu, Y., Deng, Y., Yan, S., Wang, Q., Bu, X., Zhang, X., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.10.012 · Cited by 81
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention
Thulasinathan, B., Suvilesh, K. N., Maram, S., Grossmann, E. M., Ghouri, Y. A., Teixeiro, E., Chan, J., Kaifi, J. T., & Rachagani, S. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2483780 · Cited by 88
Kim, S., Lee, J., Shin, S. G., Kim, J. K., Silwal, P., Kim, Y. J., Shin, N., Kim, P. S., Won, M., Lee, S., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1847460 · Cited by 78
Illescas, O., Rodríguez‐Sosa, M., & Gariboldi, M. (2021) · Nutrients · doi:10.3390/nu13072234 · Cited by 88
Intratumor microbiome in cancer progression: current developments, challenges and future trends
Liu, J., & Zhang, Y. (2022) · Biomarker Research · doi:10.1186/s40364-022-00381-5 · Cited by 83
Martin‐Gallausiaux, C., Salesse, L., Garcia-Weber, D., Marinelli, L., Béguet-Crespel, F., Brochard, V., Gléau, C. L., Jamet, A., Dore, J. M., Blottière, H. M., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2295384 · Cited by 85
Li, L., He, S., Liao, B., Wang, M., Lin, H., Hu, B., Lan, X., Shu, Z., Zhang, C., Yu, M., et al. (2024) · Research · doi:10.34133/research.0364 · Cited by 79
Bronzato, J. D., Bomfim, R. A., Edwards, D. H., Crouch, D. H., Hector, M., & Gomes, B. P. F. D. A. (2020) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2020.104669 · Cited by 81
Zhang, C., Wang, J., Sun, Z., Cao, Y., Mu, Z., & Ji, X. (2021) · Cancer Science · doi:10.1111/cas.14979 · Cited by 84
Wang, X., Yang, C., Zhao, Y., Xu, Z., Yang, W. Z., Wang, P., Lin, D., Xiong, B., Fang, J., Dong, C., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0089-4 · Cited by 80
Self-citationInteraction between intestinal microbiota and tumour immunity in the tumour microenvironment
Yang, X., Guo, Y., Chen, C., Shao, B., Zhao, L., Zhou, Q., Liu, J., Wang, G., Yuan, W., & Sun, Z. (2021) · Immunology · doi:10.1111/imm.13397 · Cited by 77
Gut microbiome in gastrointestinal cancer: a friend or foe?
Liu, Y., Baba, Y., Ishimoto, T., Gu, X. J., Zhang, J., Nomoto, D., Okadome, K., Baba, H., & Qiu, P. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69331 · Cited by 82
Ding, X. Q., Ting, N. L.-N., Wong, C. C., Huang, P., Бакурадзе, Н., Jiang, L., Liu, C., Lin, Y., Li, S., Liu, Y., et al. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.05.004 · Cited by 83
Shang, A., Wang, W., Yang, Y., Gu, C., Ji, P., Chen, C., Zeng, B., Wu, J., Lu, W., Sun, Z., et al. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00357.2018 · Cited by 77
Vergara, D., Simeone, P., Damato, M., Maffia, M., Lanuti, P., & Trerotola, M. (2019) · Journal of Oncology · doi:10.1155/2019/1253727 · Cited by 79
The Effects and Mechanisms of Flavonoids on Cancer Prevention and Therapy: Focus on Gut Microbiota
Wang, M., Yu, F., Zhang, Y., Chang, W., & Zhou, M. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.68170 · Cited by 81
Liu, H., Du, J., Chao, S., Li, S., Cai, H., Zhang, H., Chen, G., Liu, P., & Bu, P. (2022) · Advanced Science · doi:10.1002/advs.202105222 · Cited by 73
Huang, P., Ji, F., Cheung, A. H. K., Fu, K., Zhou, Q., Ding, X. Q., Chen, D., Lin, Y., Wang, L., Jiao, Y., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.07.001 · Cited by 81
Gallic Acid Suppresses Cardiac Hypertrophic Remodeling and Heart Failure
Xiao, Y., Zhang, Y., Zhang, L., Zou, L., Chen, C., Liu, Y., Xia, Y., & Li, H. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800807 · Cited by 78
Liu, J., Hsieh, C., Gelincik, O., Devolder, B., Sei, S., Zhang, Z., Lipkin, S. M., & Chang, Y. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2018.12.029 · Cited by 74
Human Lung Microbiome on the Way to Cancer
Kovaleva, O. V., Romashin, D. D., Zborovskaya, I. B., Давыдов, М. М., Сергеевич, Ш. М., & Gratchev, A. N. (2019) · Journal of Immunology Research · doi:10.1155/2019/1394191 · Cited by 75
Koi, M., Okita, Y., & Carethers, J. M. (2018) · Journal of the Anus Rectum and Colon · doi:10.23922/jarc.2017-055 · Cited by 78
Pourhanifeh, M. H., Vosough, M., Mahjoubin‐Tehran, M., Hashemipour, M., Nejati, M., Abbasi‐Kolli, M., Sahebkar, A., & Mirzaei, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105133 · Cited by 76
Su, W., Chen, Y., Cao, P., Chen, Y., Guo, Y., Wang, S., & Dong, W. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.594806 · Cited by 74
Self-citationFujiwara, N., Kitamura, N., Yoshida, K., Yamamoto, T., Ozaki, K., & Kudo, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176207 · Cited by 73
Lu, H., Gao, N. L., Wei, C., Wang, J., Tong, F., Li, H., Zhang, R., Ma, H., Yang, N., Zhang, Y., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00802-21 · Cited by 77
Lu, L., Dong, J., Liu, Y., Qian, Y., Zhang, G., Zhou, W., Zhao, A., Ji, G., & Xu, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.964793 · Cited by 73
Self-citationImplication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer
Singh, S., Sharma, P., Sarma, D. K., Kumawat, M., Tiwari, R. R., Verma, V., Nagpal, R., & Kumar, M. (2023) · Cancers · doi:10.3390/cancers15061913 · Cited by 83
Chen, S., Fan, L., Lin, Y., Qi, Y., Xu, C., Ge, Q., Zhang, Y., Wang, Q., Jia, D., Wang, L., et al. (2023) · 癌症：英文版 · doi:10.1002/cac2.12469 · Cited by 73
Chen, L., Kang, Z., Shen, J., Zhao, R., Miao, Y., Zhang, L., Zheng, Z., Zhang, Z., Liu, N., Wang, C., et al. (2024) · 中国科学通报：英文版 · doi:10.1016/j.scib.2024.06.016 · Cited by 76
From taxonomy to metabolic output: what factors define gut microbiome health?
Wilmanski, T., Rappaport, N., Diener, C., Gibbons, S. M., & Price, N. D. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1907270 · Cited by 73
Kong, C., Gao, R., Yan, X., Huang, L., He, J., Li, H., You, J., & Qin, H. (2019) · Science China Life Sciences · doi:10.1007/s11427-018-9456-x · Cited by 74
Yang, J., Li, D., Yang, Z., Dai, W., Feng, X., Liu, Y., Jiang, Y., Li, P., Li, Y., Tang, B., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1712986 · Cited by 78
Martin‐Gallausiaux, C., Malabirade, A., Habier, J., & Wilmes, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583644 · Cited by 73
Chau, J., Yadav, M., Liu, B., Furqan, M., Dai, Q., Shahi, S. K., Gupta, A. A., Mercer, K. N., Eastman, E., Hejleh, T. A., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08530-z · Cited by 77
The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease
Ocansey, D. K. W., Hang, S., Yuan, X., Qian, H., Zhou, M., Olovo, C. V., Zhang, X., & Mao, F. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2176118 · Cited by 71
Association between Fusobacterium nucleatum and colorectal cancer: Progress and future directions
Zhang, S., Cai, S., & Ma, Y. (2018) · Journal of Cancer · doi:10.7150/jca.24048 · Cited by 77
Benedetti, F., Curreli, S., & Zella, D. (2020) · Microorganisms · doi:10.3390/microorganisms8091351 · Cited by 80
Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma
Shi, C., Li, Z., Zheng, J., 孔为民, Fan, T., Jian, D., Cheng, X., Zhao, H., Ma, J., Tang, H., et al. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02352-6 · Cited by 74
Periodontal Pathogens and Their Links to Neuroinflammation and Neurodegeneration
Visentin, D., Gobin, I., & Maglica, Ž. (2023) · Microorganisms · doi:10.3390/microorganisms11071832 · Cited by 76
Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance
Ye, C., Liu, X., Liu, Z., Pan, C., Zhang, X., Zhao, Z., & Sun, H. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2306676 · Cited by 76
Tian, L., Zhao, Z., Xie, L., & Zhu, J. (2017) · Oncotarget · doi:10.18632/oncotarget.23513 · Cited by 71
Microbiota and Cancer: The Emerging Beneficial Role of Bifidobacteria in Cancer Immunotherapy
Longhi, G., van Sinderen, D., Ventura, M., & Turroni, F. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.575072 · Cited by 72
Zella, D., Curreli, S., Benedetti, F., Krishnan, S., Cocchi, F., Latinovic, O., Denaro, F., Romerio, F., Djavani, M. M., Charurat, M. E., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815660115 · Cited by 72
Kabwe, M., Brown, T. L., Dashper, S. G., Speirs, L. B. M., Ku, H., Petrovski, S., Chan, H. T., Lock, P., & Tucci, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-45549-6 · Cited by 76
Potential Impacts of Prebiotics and Probiotics on Cancer Prevention
Samanta, S. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621999201210220442 · Cited by 75
Gao, S., Liu, Y., Duan, X., Liu, K., Mohammed, M., Gu, Z., Ren, J., Yakoumatos, L., Yuan, X., Lü, L., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01419-5 · Cited by 74
Han, Z., Chen, Q., Zheng, D., Chen, K., Huang, Q., Zhuang, Z., & Zhang, X. (2023) · Advanced Materials · doi:10.1002/adma.202302551 · Cited by 70
Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation
Sun, J., Song, S., Liu, J., Chen, F., Li, X., & Wu, G. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00678-x · Cited by 78
Liu, X., Cheng, Y., Shao, L., & Ling, Z. (2020) · BioMed Research International · doi:10.1155/2020/2948282 · Cited by 71
Bacterial community structure alterations within the colorectal cancer gut microbiome
Loftus, M. G., Hassouneh, S. A.-D., & Yooseph, S. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02153-x · Cited by 69
Li, G., Sun, Y., Huang, Y., Lian, J., Wu, S., Luo, D., & Gong, H. (2023) · BMC Cancer · doi:10.1186/s12885-023-10844-z · Cited by 69
Tibbs, T., Lopez, L. R., & Arthur, J. C. (2019) · Microbial Cell · doi:10.15698/mic2019.08.685 · Cited by 74
Patient‐derived cancer organoids for drug screening: Basic technology and clinical application
Ren, X., Chen, W., Yang, Q., Li, X., & Xu, L. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15930 · Cited by 73
The gut microbiome affects response of treatments in HER2‐negative advanced gastric cancer
Han, Z., Cheng, S., Dai, D., Kou, Y., Zhang, X., Li, F., Yin, X., Ji, J., Zhang, Z., Wang, X., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1312 · Cited by 68
Kasper, S. H., Morell-Perez, C., Wyche, T. P., Sana, T. R., Lieberman, L. A., & Hett, E. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-62139-z · Cited by 70
Oral Bacterial and Fungal Microbiome Impacts Colorectal Carcinogenesis
Klimesova, K., Jiraskova Zakostelska, Z., & Tlaskalova-Hogenova, H. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00774 · Cited by 67
Kang, M., Kwok, R. T. K., Wang, J., Zhang, H., Lam, J. W. Y., Li, Y., Zhang, P., Zou, H., Gu, X., Li, F., et al. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00572a · Cited by 67
Role of gut microbiota in epigenetic regulation of colorectal Cancer
Zhao, Y., Wang, C., & Goel, A. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188490 · Cited by 68
Fecal Streptococcus Alteration Is Associated with Gastric Cancer Occurrence and Liver Metastasis
Yu, D., Yang, J., Jin, M., Zhou, B., Shi, L., Zhao, L., Zhang, J., Lin, Z., Ren, J., Liu, L., et al. (2021) · mBio · doi:10.1128/mbio.02994-21 · Cited by 69
Chen, D., Ning, W.-R., Li, X., Yuan, W., Lao, X., Wang, J., Wu, Y., & Zheng, L. (2018) · Autophagy · doi:10.1080/15548627.2018.1474994 · Cited by 66
Zhu, R., Lang, T., Yan, W., Zhu, X. G., Huang, X. Y., Yin, Q., & Li, Y. (2021) · Advanced Science · doi:10.1002/advs.202003542 · Cited by 65
Guo, J., Liao, M., & Wang, J. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00771-6 · Cited by 66
Lee, S. Y., Lee, D. Y., Kang, J. H., Kim, J. H., Jeong, J. W., Kim, H. W., Oh, D. H., Yoon, S. H., & Hur, S. J. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111327 · Cited by 69
Lu, X., Xu, Q., Tong, Y., Zhang, Z., Dun, G.-D., Feng, Y., Tang, J., Han, D., Mao, Y., Deng, L., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111127 · Cited by 65
Gao, Y., Zou, T., Xu, P., Wang, Y., Jiang, Y., Chen, Y., Chen, H., Hong, J., & Fang, J. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100850 · Cited by 67
Self-citationPrasad, R., Rehman, A., Rehman, L., Darbaniyan, F., Blumenberg, V., Schubert, M., Mor, U., Zamir, E., Schmidt, S., Hayase, T., et al. (2024) · Blood · doi:10.1182/blood.2024025366 · Cited by 69
Wu, C., Mamun, A. A. M. A., Luong, T. T., Hu, B., Gu, J., Lee, J. H., D’Amore, M., Das, A., & Ton‐That, H. (2018) · mBio · doi:10.1128/mbio.00360-18 · Cited by 57
Advani, S., Advani, P. G., DeSantis, S. M., Brown, D. W., VonVille, H. M., Lam, M. S., Loree, J. M., Sarshekeh, A. M., Bressler, J., López, D. S., et al. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.07.008 · Cited by 67
Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics
Ding, C., Tang, W., Fan, X., & Wu, G. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s170626 · Cited by 68
The oncogenic roles of bacterial infections in development of cancer
Eyvazi, S., Vostakolaei, M. A., Dilmaghani, A., Borumandi, O., Hejazi, M. S., Kahroba, H., & Tarhriz, V. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104019 · Cited by 68
Tumor-Associated Microbiota in Esophageal Squamous Cell Carcinoma
Yang, W., Chen, C., Jia, M., Xing, X., Gao, L., Tsai, H., Zhang, Z., Liu, Z., Zeng, B., Yeung, S. J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.641270 · Cited by 67
Gu, S., Zaidi, S., Hassan, M. I., Mohammad, T., Malta, T. M., Noushmehr, H., Nguyen, B., Crandall, K. A., Srivastav, J., Obias, V., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.09.023 · Cited by 63
Li, D., He, R., Hou, G., Ming, W., Fan, T. T., Chen, L., Zhang, L., Jiang, W., Wang, W., Lu, Z., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00268 · Cited by 65
Zhao, Z., Liu, M., Long, W., Yuan, J., Li, H., Zhang, C., Tang, G., Jiang, W., Yuan, X., Wu, M., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02153-x · Cited by 65
Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery
Jiang, J., Mei, J., Yi, S., Feng, C., Ma, Y., Liu, Y., Liu, Y., & Chen, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114046 · Cited by 68
The Role of The Tumor Microbiome in Tumor Development and Its Treatment
Chen, Y., Wu, F., Wu, P., Xing, H., & Ma, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.935846 · Cited by 68
Self-citationFu, R., Zhao, B., Chen, M., Fu, X., Zhang, Q., Cui, Y., Hu, X., & Zhou, W. (2023) · Medical Oncology · doi:10.1007/s12032-023-02237-w · Cited by 71
Broadening oncological boundaries: the intratumoral microbiota
Lu, Y.-Q., Qiao, H., Tan, X.-R., & Liu, N. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2024.01.007 · Cited by 66
Distinct intratumoral microbiome of young-onset and average-onset colorectal cancer
Barot, S. V., Sangwan, N., Nair, K. G., Schmit, S. L., Shao, X., Kamath, S. D., Liska, D., & Khorana, A. A. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.104980 · Cited by 65
Implications of gut microbiota-mediated epigenetic modifications in intestinal diseases
Zhang, Q., Liu, Y., Li, Y., Bai, G., Pang, J., Wu, M., Li, J., Zhao, X., & Xia, Y. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2508426 · Cited by 73
Effects of moderate, voluntary ethanol consumption on the rat and human gut microbiome
Kosnicki, K. L., Penprase, J. C., Cintora, P., Torres, P. J., Harris, G. L., Brasser, S. M., & Kelley, S. T. (2018) · Addiction Biology · doi:10.1111/adb.12626 · Cited by 68
Zhang, X., Zhu, X., Cao, Y., Fang, J., Hong, J., & Chen, H. (2019) · Cancer Medicine · doi:10.1002/cam4.1850 · Cited by 65
Self-citationMicrobial exposure and human health
Sharma, A., & Gilbert, J. A. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.08.003 · Cited by 67
Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy
Zhang, X., Liu, Q., Liao, Q., & Zhao, Y. (2020) · Journal of Cancer · doi:10.7150/jca.37445 · Cited by 68
Inamura, K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.006 · Cited by 63
Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease
Pavel, F. M., Vesa, C. M., Gheorghe, G., Diaconu, C. C., Stoicescu, M., Munteanu, M. A., Babeş, E. E., Ţiţ, D. M., Toma, M. M., & BUNGAU, S. G. (2021) · Diagnostics · doi:10.3390/diagnostics11061090 · Cited by 67
Wang, H., Wang, X., Zhang, H., Deng, T., Liu, R., Liu, Y., Li, H., Bai, M., Ning, T., Wang, J., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01898-z · Cited by 64
Nie, F., Zhang, J., Tian, H., Zhao, J., Gong, P., Wang, H., Wang, S., Yang, P., & Yang, C. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06640-7 · Cited by 68
The impact of the intestinal microbiome on bone health
Zhang, J., Lu, Y., Wang, Y., Ren, X., & Han, J. (2018) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2018.01055 · Cited by 67
Self-citationThe effect of periodontal bacteria infection on incidence and prognosis of cancer
Li, X., Zhang, Q., Peng, Y., Wang, D., & Liu, Y. (2020) · Medicine · doi:10.1097/md.0000000000019698 · Cited by 66
Tumor-Associated Microbiome: Where Do We Stand?
Oliva, M., Mulet-Margalef, N., Ochoa-de-Olza, M., Napoli, S., Mas-Lloret, J., Laquente, B., Alemany, L., Duell, E. J., Nuciforo, P. G., & Moreno, V. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031446 · Cited by 63
Huyghe, N. D., Benidovskaya, E., Stevens, P., & den Eynde, M. V. (2022) · Cancers · doi:10.3390/cancers14092241 · Cited by 65
Bitar, S. A., El-Sabban, M. E., Doughan, S., & Abou-Kheir, W. G. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i9.1395 · Cited by 69
Wang, X., Chen, Q., Zhu, Y., Wang, K., Chang, Y., Wu, X., Bao, W., Cao, T., Chen, H., Zhang, Y., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01491-8 · Cited by 64
Self-citationCommensal fungi in intestinal health and disease
Ost, K. S., & Round, J. L. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00816-w · Cited by 69
Fusobacterium nucleatum: ecology, pathogenesis and clinical implications
Jiang, S., Chen, Y., & Fang, J. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01237-z · Cited by 76
Self-citation
Metadata
- Authors
- Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., Chen, Y., Chen, H., Hong, J., Zou, W., & Fang, J.-Y.
- Affiliations
- Shanghai Jiao Tong University (CN)
- University of Michigan (US)
- Corresponding author
- Chen, Yingxuan
- Chen, Haoyan
- Hong, Jie
- Zou, Weiping
- Fang, Jing-Yuan
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 170
- Issue
- 3
- Pages
- 548-563.e16
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC5767127
- OpenAlex
- W2742147437
- Cited by
- 2,198
- References
- 50
- Citations by year
- 2026: 265 · 2025: 291 · 2024: 300 · 2023: 323 · 2022: 287 · 2021: 268 · 2020: 214 · 2019: 124 · 2018: 105 · 2017: 17
- FWCI
- 51.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Natural Science Foundation of China (81421001, 81320108024, 81530072, 81522008 31371273, 31371420, 81572303, 81001070)
- National Key Technology R&D Program (2014BAI09B05)
- Program for Professor of Special Appointment (Eastern Scholar No. 201268, 2015 Youth Eastern Scholar NO.QD2015003)
- Shanghai Institutions of Higher Learning, the Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Grant (20152512, 20161309)
- National Cancer Institute (CA211016)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- Fusobacterium nucleatum, colorectal cancer, chemoresistance, autophagy, gut microbiota, TLR4, MyD88, microRNA, innate immune signaling, chronic inflammation
- MeSH terms
- Gastrointestinal Microbiome, Capecitabine, Animals, Antineoplastic Agents, Autophagy, Neoplasm Transplantation, Recurrence, Colorectal Neoplasms, Fusobacterium nucleatum, Platinum Compounds, Drug Resistance, Neoplasm, MicroRNAs, Toll-Like Receptors, Mice, Tumor Microenvironment, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
